Hips — Revenue
Zimmer Biomet Holdings Hips — Revenue decreased by 5.6% to $524.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.7%, from $495.80M to $524.10M. Over 4 years (FY 2021 to FY 2025), Hips — Revenue shows an upward trend with a 3.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market share or higher procedure volumes for hip replacement surgeries, while a decrease may signal competitive pressure, pricing erosion, or a decline in elective surgical volumes.
Detailed definition
This metric represents the total net sales generated from the Hips product category, which includes orthopedic reconstru...
Peer comparison
Comparable to revenue reporting for orthopedic reconstructive segments at major medical device competitors, often benchmarked against total joint replacement market growth rates.
zbh_segment_hips_revenue_from_contract_with_customer_excluding_assessed_taxHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $474.50M | $453.90M | $480.70M | $451.00M | $487.20M | $468.00M | $488.70M | $492.80M | $504.30M | $465.30M | $504.70M | $491.20M | $506.50M | $481.50M | $520.00M | $495.80M | $536.10M | $506.20M | $555.40M | $524.10M |
| QoQ Change | — | -4.3% | +5.9% | -6.2% | +8.0% | -3.9% | +4.4% | +0.8% | +2.3% | -7.7% | +8.5% | -2.7% | +3.1% | -4.9% | +8.0% | -4.7% | +8.1% | -5.6% | +9.7% | -5.6% |
| YoY Change | — | — | — | — | +2.7% | +3.1% | +1.7% | +9.3% | +3.5% | -0.6% | +3.3% | -0.3% | +0.4% | +3.5% | +3.0% | +0.9% | +5.8% | +5.1% | +6.8% | +5.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Zimmer Biomet Holdings's hips — revenue?
- Zimmer Biomet Holdings (ZBH) reported hips — revenue of $524.10M in Q1 2026.
- How has Zimmer Biomet Holdings's hips — revenue changed year-over-year?
- Zimmer Biomet Holdings's hips — revenue increased by 5.7% year-over-year, from $495.80M to $524.10M.
- What is the long-term trend for Zimmer Biomet Holdings's hips — revenue?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's hips — revenue has grown at a 3.1% compound annual growth rate (CAGR), from $1.86B to $2.09B.
- What does hips — revenue mean?
- The total revenue earned from the sale of hip replacement implants and associated surgical products.